PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of ketorolac tromethamine tablets, USP to its current portfolio.

Ketorolac tromethamine tablets are indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with IV or IM dosing of ketorolac tromethamine, and ketorolac tromethamine tablets are to be used only as continuation treatment, if necessary.

Ketorolac tromethamine, USP 10 mg are available in 100 count bottles.